Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 4 |
List of Tables | 4 | 1 |
List of Figures | 5 | 1 |
Biohit Oyj, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
Biohit Oyj, Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
Biohit Oyj, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
Biohit Oyj, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
Biohit Oyj, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
Biohit Oyj, Medical Equipment, Deal Details | 11 | 14 |
Asset Purchase | 11 | 1 |
Biohit Acquires Rights To UFT300 Test From Advanced Biomedical Systems For US$0.5 Million | 11 | 1 |
Partnerships | 12 | 1 |
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test | 12 | 1 |
Biohit Enters into Distribution Agreement with Pooyandegan Pezeshki Pardis | 13 | 1 |
Biohit Enters into Distribution Agreement with Genetic Analysis | 14 | 1 |
Biohit Enters Into Distribution Agreement With Dynex Technologies | 15 | 1 |
Biohit Forms Joint Venture with Anhui Wisdom-Win Investment | 16 | 1 |
Ferring Pharma Enters Into Distribution Agreement With Biohit Healthcare For PreventID CalScreen | 17 | 1 |
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel | 18 | 1 |
Biohit Enters Into Distribution Agreement With Hefei Medicine For GastroPanel Test | 19 | 1 |
Biohit Enters Into Distribution Agreement With Fisher Scientific For Diagnostic Products | 20 | 1 |
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel | 21 | 1 |
Debt Offering | 22 | 1 |
Biohit Completes Private Placement of 6.5% Convertible Bonds Due 2015 for USD5.3 Million | 22 | 1 |
Acquisition | 23 | 1 |
Biohit Acquires 18% Stake in Genetic Analysis | 23 | 1 |
Biohit Completes Acquisition of Euroclone Gastro from Euroclone for USD1.48 Million | 24 | 1 |
Biohit Oyj - Key Competitors | 25 | 1 |
Key Employees | 26 | 1 |
Locations And Subsidiaries | 27 | 1 |
Head Office | 27 | 1 |
Other Locations &Subsidiaries | 27 | 1 |
Recent Developments | 28 | 1 |
Financial Announcements | 28 | 1 |
Aug 18, 2016: Biohit Group Half Year Financial report 2016 | 28 | 14 |
Aug 20, 2015: Biohit Group Interim Report Q2/2015 | 42 | 5 |
May 07, 2015: Biohit Group interim report Q1-2015 | 47 | 2 |
Feb 26, 2015: Biohit Group Financial Statement Release 2014 | 49 | 3 |
Corporate Communications | 52 | 1 |
Aug 26, 2016: Ilari Patrakka appointed Biohit Oyj s Sales and Marketing Director | 52 | 1 |
Government and Public Interest | 53 | 1 |
Apr 15, 2015: Recommendations for detection of gastric cancer risk and monitoring of the cancer precursors | 53 | 1 |
Product News | 54 | 1 |
Feb 20, 2015: BIOHIT ColonView is the best colorectal cancer screening test on the market | 54 | 1 |
Other Significant Developments | 55 | 1 |
May 04, 2015: Mekalasi Oy to distribute Biohit Quick Tests in Finland | 55 | 1 |
Mar 23, 2015: Biohit and Gulf Drug to sign a distributor agreement | 56 | 1 |
Jan 29, 2015: Biohit and Ympyratalo Pharmacy to co-operation | 57 | 1 |
Appendix | 58 | 1 |
Methodology | 58 | 1 |
About GlobalData | 58 | 1 |
Contact Us | 58 | 1 |
Disclaimer | 58 | 1 |